Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma

Journal of Thoracic Oncology

Volumn 4, Issue 2, 2009, Pages 227-239

  Buys, Timon P H ^a   Aviel Ronen, Sarit ^b   Waddell, Thomas K ^c   Lam, Wan L ^a   Tsao, Ming Sound ^d  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b SHEBA MEDICAL CENTER   (Israel)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Array CGH; Breakpoint; Clonal; Combined carcinoma; LCNEC; SCLC

Indexed keywords

ANTIBIOTIC AGENT; CD56 ANTIGEN; CHROMOGRANIN A; TUMOR MARKER;

AGED; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CASE REPORT; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; HEMANGIOMA; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MOLECULAR CLONING; PNEUMONIA; PRIORITY JOURNAL; ADENOCARCINOMA; CARCINOMA; CHROMOSOME ABERRATION; GENETICS; HUMAN GENOME; IMMUNOPHENOTYPING; LUNG TUMOR; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; GENOME, HUMAN; HUMANS; IMMUNOPHENOTYPING; LUNG NEOPLASMS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 65649086486     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181952678     Document Type: Article

References (30)

1. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:606-612.
2. Petersen I, Petersen S. Towards a genetic-based classification of human lung cancer. Anal Cell Pathol 2001;22:111-121.
3. Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J. Clonality of combined tumors. Arch Pathol Lab Med 2002;126:437-441.
4. Murase T, Takino H, Shimizu S, et al. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung. Hum Pathol 2003;34:1178-1184.
5. Fellegara G, D'Adda T, Pilato FP, et al. Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma. Virchows Arch 2008;453:107-115.
6. D'Adda T, Pelosi G, Lagrasta C, et al. Genetic alterations in combined neuroendocrine neoplasms of the lung. Mod Pathol 2008;21:414-422.
7. Gallegos Ruiz MI, van Cruijsen H, Smit EF, et al. Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases. J Thorac Oncol 2007;2:12-21.
8. Watson SK, deLeeuw RJ, Horsman DE, Squire JA, Lam WL. Cytogenetically balanced translocations are associated with focal copy number alterations. Hum Genet 2007;120:795-805.
9. Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 2003;63:8582-8585.
10. Khojasteh M, Lam WL, Ward RK, MacAulay C. A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 2005;6:274.
11. Chi B, deLeeuw RJ, Coe BP, Ng RT, MacAulay C, Lam WL. MD-SeeGH: a platform for integrative analysis of multi-dimensional genomic data. BMC Bioinformatics 2008;9:243.
12. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 2004;20:3636-3637.
13. Chari R, Lockwood WW, Coe BP, et al. SIGMA: a system for integrative genomic microarray analysis of cancer genomes. BMC Genomics 2006;7:324.
14. Ullmann R, Schwendel A, Klemen H, Wolf G, Petersen I, Popper HH. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization. Hum Pathol 1998;29: 1145-1149.
15. Ullmann R, Petzmann S, Sharma A, Cagle PT, Popper HH. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Hum Pathol 2001;32:1059-1063.
16. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877-6883.
17. Peng WX, Shibata T, Katoh H, et al. Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung. Cancer Sci 2005;96:661-667.
18. Choi JS, Zheng LT, Ha E, et al. Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. Lung 2006;184:355-362.
19. Durkin SG, Glover TW. Chromosome fragile sites. Annu Rev Genet 2007;41:169-192.
20. Lukusa T, Fryns JP. Human chromosome fragility. Biochim Biophys Acta 2008;1179:3-16.
21. Coe BP, Lockwood WW, Girard L, et al. Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. Br J Cancer 2006;94:1927-1935. (Pubitemid 43882587)
22. Garnis C, Lockwood WW, Vucic E, et al. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int J Cancer 2006;118:1556-1564.
23. Kim TM, Yim SH, Lee JS, et al. Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers. Clin Cancer Res 2005;11:8235-8242.
24. Shibata T, Uryu S, Kokubu A, et al. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res 2005;11:6177-6185.
25. Tonon G, Wong KK, Maulik G, et al. High-resolution genomic profiles of human lung cancer. Proc Natl Acad Sci USA 2005;102:9625-9630.
26. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007;450:893-898.
27. Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005;24:4741-4753.
28. Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res 2007;13:3229-3234.
29. Sjoblom T. Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes. Curr Opin Oncol 2008;201:66-71.
30. Wilson IM, Davies JJ, Weber M, et al. Epigenomics: mapping the methylome. Cell Cycle 2006;5:155-158.